Inventor
WAN ZEHONG
CN35 patents
⚠️ This page may combine multiple inventors who share the name “WAN ZEHONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GLAXO GROUP LTD
12 patentsUS7439255B2Oct 21, 2008
Muscarinic acetylcholine receptor antagonists
GLAXO GROUP LTD14 citations92
US7276521B2Oct 2, 2007
Muscarinic acetylcholine receptor antagonists
GLAXO GROUP LTD34 citations91
US7563803B2Jul 21, 2009
M3 muscarinic acetylcholine receptor antagonists
GLAXO GROUP LTD5 citations73
US7479558B2Jan 20, 2009
Process for preparing pyrido[2,3-d]pyrimidin-7-one and 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one derivatives
GLAXO GROUP LTD5 citations62
US7579361B2Aug 25, 2009
Muscarinic acetylcholine receptor antagonists
GLAXO GROUP LTD2 citations61
US7576096B2Aug 18, 2009
Muscarinic acetylcholine receptor antagonists
GLAXO GROUP LTD3 citations61
US7678801B2Mar 16, 2010
Compounds
GLAXO GROUP LTD2 citations60
US9174968B2Nov 3, 2015
Pyrimidinone compounds for use in the treatment of diseases or conditions mediated by LP-PLA2
GLAXO GROUP LTD1 citations52
US7906531B2Mar 15, 2011
M3 muscarinic acetylcholine receptor antagonists
GLAXO GROUP LTD0 citations51
US7674789B2Mar 9, 2010
Compounds
GLAXO GROUP LTD1 citations51
US8354416B2Jan 15, 2013
7,8-dihydropyrido[2,3-d]pyrimidin-4-yl substituted compounds as inhibitors of p38 kinase
GLAXO GROUP LTD0 citations50
US7507747B2Mar 24, 2009
Muscarinic acetylcholine receptor antagonists
GLAXO GROUP LTD1 citations50
GLAXOSMITHKLINE IP DEV LTD
11 patentsUS9783546B2Oct 10, 2017
Compounds
GLAXOSMITHKLINE IP DEV LTD2 citations73
US9815841B2Nov 14, 2017
Compounds
GLAXOSMITHKLINE IP DEV LTD2 citations69
US10975081B2Apr 13, 2021
Substituted fused pyrazole compounds and their use as LRRK2 inhibitors
GLAXOSMITHKLINE IP DEV LTD1 citations61
US10618901B2Apr 14, 2020
LRRK2 inhibitors for the treatment of Parkinson's disease
GLAXOSMITHKLINE IP DEV LTD1 citations60
US11999746B2Jun 4, 2024
Compounds
GLAXOSMITHKLINE IP DEV LTD0 citations59
US10125141B2Nov 13, 2018
Compounds
GLAXOSMITHKLINE IP DEV LTD1 citations59
US9051325B2Jun 9, 2015
Bicyclic [5,6] imidazo pyrimodone compounds for use in the treatment of diseases or conditions mediated by Lp-PLA2
GLAXOSMITHKLINE IP DEV LTD0 citations51
US10087186B2Oct 2, 2018
Compounds as LRRK2 kinase inhibitors
GLAXOSMITHKLINE IP DEV LTD1 citations50
US10428078B2Oct 1, 2019
Compounds
GLAXOSMITHKLINE IP DEV LTD0 citations49
US9296755B2Mar 29, 2016
3,4-dihydro-1H-pyrimido[1,6-a]pyrimidin-6(2H)-one compounds and their therapeutic applications
GLAXOSMITHKLINE IP DEV LTD0 citations42
US9708330B2Jul 18, 2017
2,3-dihydroimidazol[1,2-C]pyrimidin-5(1-H)-one based ipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitors
GLAXOSMITHKLINE IP DEV LTD0 citations40
WAN ZEHONG
4 patentsUS8975400B2Mar 10, 2015
2,3-dihydroimidazo[1, 2-c] pyrimidin-5(1 H)-one compounds use as LP-PLA2 inhibitors
WAN ZEHONG2 citations59
US8859573B2Oct 14, 2014
Pyrimidinone and pyridinone compounds for use in the treatment of diseases or conditions mediated by Lp-PLA2
WAN ZEHONG1 citations50
US9273054B2Mar 1, 2016
Substituted pyrimido[1,6-a]pyrimidines as Lp-PLA2 inhibitors
WAN ZEHONG1 citations49
US8871928B2Oct 28, 2014
Tricyclic compounds, preparation methods, and their uses
WAN ZEHONG0 citations42
SMITHKLINE BEECHAM CORP
3 patentsCALLAHAN JAMES FRANCIS
3 patentsUS8084449B2Dec 27, 2011
Dual pharmacophores—PDE4-muscarinic antagonistics
CALLAHAN JAMES FRANCIS2 citations48
US8067408B2Nov 29, 2011
Dual pharmacophores—PDE4-muscarinic antagonistics
CALLAHAN JAMES FRANCIS1 citations48
US8071588B2Dec 6, 2011
Dual pharmacophores—PDE4-muscarinic antagonistics
CALLAHAN JAMES FRANCIS0 citations37